Exact Sciences Announces First Quarter 2022 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/19/2026
- Wall St futures flat after tech rout; Iran tensions, retail earnings in focus
- Nvidia credit risk gauge hits new peak as SoftBank readies record bond issue
- Target raises full-year sales forecast amid ongoing turnaround drive
- Global bond rout pauses as sovereign yields back off multi-decade highs
- Lowe's slashes full-year sales outlook amid DIY spending pressure
- Tech selloff weighs down Wall Street as bond yields climb
- Marvell issues Google warrant tied to custom chip deal
- Lowe's Cos. (LOW) Tops Q2 EPS by 17c, Misses on Revenue; Offers Fy27 Guidance
- Francisco Partners to acquire Weave Communications for $650M
- Nvidia or Sandisk? BofA reveals which stock is under-owned and which is crowded
Exact Sciences (EXAS) Tops Q1 EPS by 3c
April 26, 2022 4:10 PM EDTExact Sciences (NASDAQ: EXAS) reported Q1 EPS of ($1.04), $0.03 better than the analyst estimate of ($1.07). Revenue for the quarter came in at $487 million versus the consensus estimate of $461.71 million.
GUIDANCE:
Exact Sciences sees FY2022 revenue of $1.985-2.032 billion, versus the consensus of $2.01... More
